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Microorganisms occur nearly everywhere in nature and occupy an important place 
in human view of life. Marine microbes represent a potential source for commercially 
important bioactive compounds for the decrease of discovering novel bioactive 
metabolites from terrestrial organisms in recent years，the hot spot has been focused on 
the much more complex marine resources. 
 
The genus micromonospora has a complex life cycle, which includes 
differentiation into substrate mycelia, aerial hyphae and spore production, allows 
micromonospora strains to play an active role in the degradation of organic matter in their 
natural habitats. They are also known as producers of a wide variety of antibiotics, among 
which aminoglycosides are the most abundant. 
 
From the secondary metabolites of the micromonospora strains a lot of 
compounds with new structures and great bioactive diversities could be found. So the 
study of micromonospora strains from the soil samples and marine samples was an 
effective method for the development of medicine compounds. 
 
The present study is aimed for the isolation and activities studies of 
Micromonosporae strains from mangrove sediments of Xiamen, which were isolated in 
the laboratory of microbial pharmaceutical sciences, Xiamen University.  
 
In this thesis we describe the isolation, fermentation, metabolites extractions and 
biological activities tests of micromonospora strains isolated from mangrove sediments of 
Xiamen, we also describe the separation process of compound CI-1 isolated from Strain 
B3-1 and the activities of its fractions separated with RP-18.This work will give aide to 

















From mangrove sediments of Xiamen, 255 Micromonosporae strains were 
isolated. Crude fermentation extraction of each strain was tested by three different 
bioactive screening programs including anti-bacterial activity, anti-fungi activity and anti-
tumor activity. 
The result of bioactive tests showed that 181strains of micromonospora displayed 
one or more than one bioactivities on five indicator organisms of bacteria, 69 strains 
displayed anti-fungi activities on one or both 2 fungi organisms and 35 strains displayed 
anti-tumor activities on Hela cell line. 
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AN: Asperignous Niger  
ATCC: American type culture collection (Rockland, Maryland/USA) 
bp: Base pair(s) 
BP: Bacillus Pulmilus  
BS: Bacillus Subtilis  
C: Chloroform 
CA: Candida Albicans  
CFU: Colony forming units 
CH: Cyclohexane 
DMEM: Dulbecco’s modified Eagle medium 
DMSO: Dimethyl sulfoxide 
DNA: Deoxyribonucleic acid 
DNase: Deoxyribonuclease 
Drop/min: drop per minute 
Drop/tube: drop per tube 
E- coli: Escherichia Coli  
EDTA: Ethylenediamine tetra acetic acid 
EA: Ethyl acetate 




G: Gravity (relative centrifugal force) 
H: hour 
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